Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 53.40M | $ 65.49M | $ 47.64M | $ 38.35M | $ 62.90M |
| Gross Profit | $ 29.08M | $ 42.51M | $ 28.05M | $ 22.00M | $ 52.02M |
| Operating Income | $ 3.92M | $ 10.46M | $ -13.01M | $ -20.46M | $ 1.85M |
| EBITDA | $ 6.52M | $ 11.65M | $ -10.78M | $ -18.94M | $ 4.45M |
| Net Income | $ 2.93M | $ 8.31M | $ -14.93M | $ -33.98M | $ -14.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 34.83M | $ 44.56M | $ 22.18M | $ 38.98M | $ 38.55M |
| Total Assets | $ 73.42M | $ 84.43M | $ 55.79M | $ 73.67M | $ 67.93M |
| Total Debt | $ 5.53M | $ 26.28M | $ 33.47M | $ 33.47M | $ 64.40M |
| Net Debt | $ -14.23M | $ 2.65M | $ 16.36M | $ -5.51M | $ 46.13M |
| Total Liabilities | $ 30.21M | $ 50.87M | $ 66.43M | $ 79.70M | $ 94.97M |
| Stockholders' Equity | $ 43.21M | $ 33.57M | $ -10.64M | $ -6.04M | $ -27.04M |
| Cash Flow | |||||
| Free Cash Flow | $ 7.39M | $ -2.47M | $ -25.63M | $ -11.74M | $ -26.76M |
| Operating Cash Flow | $ 8.67M | $ -1.32M | $ -25.00M | $ -10.29M | $ -26.11M |
| Investing Cash Flow | $ 4.22M | $ -16.71M | $ -5.04M | $ 18.92M | $ -19.95M |
| Financing Cash Flow | $ -16.79M | $ 24.67M | $ 8.24M | $ 12.08M | $ 46.47M |